31 – 40 of 467
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cardiovascular magnetic resonance derived pressure volume loop variables in patients with ST-elevation myocardial infarction provide physiological information beyond ejection fraction
2023) Svenska kardiovaskulära vårmötet(
- Contribution to conference › Poster
-
Mark
Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Cardiovascular magnetic resonance derived pressure volume loop variables in patients with ST-elevation myocardial infarction provide physiological information beyond ejection fraction
2023) Svensk förening för klinisk fysiologi - Höstmötet 2023(
- Contribution to conference › Poster
-
Mark
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI : The time has arrived
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Relation of Early Monomorphic Ventricular Tachycardia to Long-Term Mortality in ST-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable : validation in multi-centre multi-vendor data
(
- Contribution to journal › Article
-
Mark
Patient-oriented risk score for predicting death 1 year after myocardial infarction : the SweDen risk score
(
- Contribution to journal › Article
-
Mark
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction : a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
On the Natural History of Coronary Artery Disease : A Longitudinal Nationwide Serial Angiography Study
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
(
- Contribution to journal › Article